Skip to content

Margetuximab

Published: July 26, 2026Updated: July 26, 2026

Margenza (margetuximab-cmkb) is a prescription monoclonal antibody medication used to treat adults with HER2-positive metastatic breast cancer who have previously received at least two anti-HER2 treatments (at least one for metastatic disease). It is administered via intravenous infusion in combination with chemotherapy.

Quick summary

A HER2-targeted monoclonal antibody used for HER2-positive metastatic breast cancer that has progressed after prior anti-HER2 therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

RxNorm
2474029
Generic
Margenza
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Metastatic HER2-positive breast cancer in adults who have received at least two prior anti-HER2 regimens, with at least one used for metastatic disease. Used in combination with chemotherapy.

Margenza is a Fc-engineered monoclonal antibody that binds to the HER2 protein on cancer cells, inhibiting tumor cell proliferation and mediating antibody-dependent cellular cytotoxicity (ADCC). The modified Fc region is designed to enhance immune effector function.

Administered as an intravenous infusion every 3 weeks. Requires cardiac monitoring due to risk of left ventricular dysfunction. Infusion-related reactions may occur. Not interchangeable with other HER2-targeted therapies. Should only be used by healthcare providers experienced in cancer treatment.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy